SKN | Apnimed Targets $150 Million IPO to Advance Late-Stage Sleep Apnea Therapy
Apnimed, a late-stage biopharmaceutical company developing an oral treatment for obstructive sleep apnea (OSA), has set the terms for its initial public offering (IPO),...
SKN | Yorkville America Investment Trust Prepares for Market Debut as Investors Assess New ETF Opportunities
Yorkville America Investment Trust is preparing for its public market debut, offering investors another avenue to access professionally managed investment strategies through the expanding...
SKN | Trinity Capital Inc. Eyes Next Phase of Growth as Investors Assess Market Opportunities
Trinity Capital Inc. is drawing renewed attention from investors as the specialty finance company continues expanding its capital markets presence. Its latest offering underscores...
SKN | IPO Market Enters Critical Summer Window as Jersey Mike’s, Reformation, and Biotech Listings Drive Momentum
The U.S. initial public offering market is entering one of its most active periods before the traditional August slowdown, with several high-profile consumer brands...
SKN | Pelican Acquisition II Raises $75 Million SPAC IPO to Pursue Global Technology Companies
Pelican Acquisition II has completed its initial public offering (IPO), raising $75 million through a special purpose acquisition company (SPAC) focused on identifying technology...